Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of Oral Vaccines in these regions, from 2012 to 2023 (forecast), covering
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global Oral Vaccines market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the

top players including

GlaxoSmithKline Plc.
PaxVax Corporation
Pfizer Inc
Merial, Inc.
Merck Sharp & Dohme Corp
VALNEVA Canada Inc.
QUíMICA SUIZA S.A
Immunitor, Inc
Aventis (Sanofi S.A.)
Serum Institute of India Pvt. Ltd
Swiss Serum and Vaccine Institute Berne
Bull Bio - NCIPD Ltd.
Vaxart, Inc.
Shantha Biotechnics
Crucell (Janssen Global Services, LLC)

On the basis of product

, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Live Attenuated Vaccines
Killed/Inactivated Vaccines
Recombinant Vaccines
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Oral Vaccines for each application, including
Polio
Rabies
Rotavirus
Cholera
HIV
Respiratory Infections
Influenza
Tuberculosis
Others

If you have any special requirements, please let us know and we will offer you the report as you want.